Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)
Timo Strandberg, Petri T. Kovanen, Donald M. Lloyd‐Jones, Frederick J. Raal, Raúl D. Santos, Gerald F. Watts
Topics & Concepts
SimvastatinMedicineInternal medicineHydroxymethylglutaryl-CoA Reductase InhibitorsPharmacologyOncologyStatinLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsLipid metabolism and disorders